Fresenius SE & Co. KGaA / Key word(s): Change in Forecast 29.07.2015 22:16 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Fresenius raises 2015 earnings guidance Based on the excellent financial results in the first half of 2015 and excellent prospects for the remainder of the year, Fresenius raises its 2015 earnings guidance. Fresenius now expects net income* growth of 18% to 21% in constant currency. Previously, the company expected net income* growth of 13% to 16% in constant currency. The company fully confirms its Group sales guidance. Sales are now expected to increase by 8% to 10% in constant currency (previously: 7% to 10%). Based on the excellent financial results in the first half of 2015 and excellent prospects for the remainder of the year, particularly in North America, Fresenius Kabi raises its 2015 guidance. Fresenius Kabi now expects organic sales growth of 6% to 8%. EBIT growth in constant currency is expected to be in the range of 18% to 21%. Previously, Fresenius Kabi projected organic sales growth of 4% to 7% and EBIT growth in constant currency in the range of 11% to 14%. * Net income attributable to shareholders of Fresenius SEâ&âCo.âKGaA; 2015 before integration costs (~EUR10 million before tax for hospitals acquired from Rhön-Klinikum AG), before costs for the efficiency program at Fresenius Kabi (~EUR100 million before tax), and before the disposal gain from the divestment of two HELIOS hospitals (EUR34 million before tax); 2014 before special items (Financial statements according to U.S. GAAP) Fresenius SE & Co. KGaA, represented by Fresenius Management SE, Board of Management Bad Homburg v.d.H., July 29, 2015 End of note 29.07.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Fresenius SE & Co. KGaA Else-Kröner-StraÃe 1 61352 Bad Homburg v.d.H. Germany Phone: +49 (0)6172 608-2485 Fax: +49 (0)6172 608-2488 E-mail: ir-fre@fresenius.com Internet: www.fresenius.com ISIN: DE0005785604 WKN: 578560 Indices: DAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises 2015 earnings guidance
| Source: EQS Group AG